...
首页> 外文期刊>European review for medical and pharmacological sciences. >MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1
【24h】

MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1

机译:MicroRNA-424-5P通过与ITGB1结合来抑制非小细胞LCA的发育

获取原文
           

摘要

OBJECTIVE: The aim of this study was to explore the effect of microRNA-424-5p on the proliferation and apoptosis of non-small cell lung cancer (NSCLC) cells, and to investigate its influence on the expression of ITGB1 and potential regulatory mechanism. PATIENTS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was used to detect the level of microRNA-424-5p in 44 paired NSCLC tissues and adjacent tissues. The relation between microRNA-424-5p expression and NSCLC clinical indicators was analyzed. Subsequently, microRNA-424-5p mimics and inhibitors were transfected into NSCLC cells to construct microRNA-424-5p overexpression or knockdown models, respectively. QRT-PCR was used to further verify the transfection efficiency. A series of experiments, including cell counting kit-8 (CCK-8) assay, colony formation, 5-Ethynyl-2’-deoxyuridine (EdU), and flow cytometry were used to analyze the effect of microRNA-424-5p on the biological function of NSCLC A549 and H358 cells. Finally, the potential association between microRNA-424-5p and its downstream gene ITGB1 was explored through luciferase reporter gene assay and cell recovery experiment. RESULTS: QRT-PCR results showed that microRNA-424-5p level was significantly lower in NSCLC tissues than that of adjacent normal tissues. Compared with patients with high expression of microRNA-424-5p, the pathological stage of those with low expression of microRNA-424-5p was significantly higher. In vitro experiments showed that microRNA-424-5p overexpression remarkably decreased cell proliferation and increased cell apoptosis, which were further validated in microRNA-424-5p inhibitor group. Subsequently, ITGB1 expression was found significantly up-regulated in NSCLC cell lines and tissues. Meanwhile, ITGB1 expression was negatively correlated with microRNA-424-5p level. In addition, a recovery experiment indicated that overexpression of ITGB1 could counteract the effect of microRNA-424-5p mimics on the proliferation and apoptosis of NSCLC cells. All these findings revealed that microRNA-424-5p and ITGB1 affected the malignant progression of NSCLC. CONCLUSIONS: MicroRNA-424-5p was closely correlated with the pathological stage and poor prognosis of NSCLC, thereby inhibiting the occurrence and development of NSCLC.
机译:目的:本研究的目的是探讨microRNA-424-5P对非小细胞肺癌(NSCLC)细胞增殖和凋亡的影响,并研究其对ITGB1表达的影响和潜在的调节机制。患者和方法:使用定量的实时 - 聚合酶链反应(QRT-PCR)检测44个配对的NMSCLC组织和相邻组织中的MicroRNA-424-5P水平。分析了MicroRNA-424-5P表达与NSCLC临床指标之间的关系。随后,将MicroRNA-424-5P模拟物和抑制剂转染到NMSCLC细胞中,以分别构建微小RONE-424-5P过表达或敲低模型。 QRT-PCR用于进一步验证转染效率。一系列实验,包括细胞计数试剂盒 - 8(CCK-8)测定,菌落形成,5-乙炔基-2'-脱氧尿苷(EDU)和流式细胞术用于分析MICRRNA-424-5P对的影响NSCLC A549和H358细胞的生物学功能。最后,通过荧光素酶报告基因测定和细胞回收实验探索了MicroRNA-424-5P与其下游基因ITGB1之间的潜在关联。结果:QRT-PCR结果表明,NSCLC组织中微小RNA-424-5P水平显着低于相邻正常组织的水平。与MicroRNA-424-5P高表达的患者相比,MicroRNA-424-5P表达低的病理阶段显着高。体外实验表明,MicroRNA-424-5P过度表达显着降低,细胞增殖和增加的细胞凋亡增加,其在microRNA-424-5P抑制剂组中进一步验证。随后,在NSCLC细胞系和组织中发现ITGB1表达显着上调。同时,ITGB1表达与MicroRNA-424-5P水平负相关。此外,恢复实验表明ITGB1的过度表达可以抵消MicroRNA-424-5P模拟对NSCLC细胞增殖和凋亡的影响。所有这些发现透露,MicroRNA-424-5P和ITGB1影响了NSCLC的恶性进展。结论:MicroRNA-424-5P与病态阶段密切相关,NSCLC预后差,从而抑制NSCLC的发生和发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号